BALTIMORE (WJZ) — The U.S. Food and Drug Administration has approved an injection called Giapreza.

The injection is for intravenous infusion to increase blood pressure in adults with septic or other distributive shock. The approval came on Thursday.

According to officials at the FDA, shock is the inability to maintain blood flow to vital tissues and can result in organ failure and death. Norman Stockbridge, the director of the Division of Cardiovascular and Renal Products in the FDA’s Center for Drug Evaluation and Research, says “there is a need for treatment options for critically ill hypotensive patients who do not adequately respond to available therapies.”

Shock is a critical condition in which blood pressure drops so low the brain, kidneys, and other vital organs can’t receive enough blood flow to function properly.

In a clinical treatment trial Giapreza effectively increased blood pressure when added to conventional treatments used to raise blood pressure.

The FDA granted the approval of Giapreza to La Jolla Pharmaceutical Company.

Follow @CBSBaltimore on Twitter and like WJZ-TV | CBS Baltimore on Facebook

Comments
  1. Believe it or not, blood pressure is something that can be easily balanced out if you follow the steps in this video. https://youtu.be/iLjA9ipbaPA

Leave a Reply

Please log in using one of these methods to post your comment:

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

More From CBS Baltimore

Track Weather On The Go With Our App!
CBS All Access
Download Our App

Watch & Listen LIVE